Is the use of Ro 10-9359 (Tigason) in children justified?
Van der Rhee, H.J.; van Gelderen, H.H.; Polano, M.K.
Acta Dermato-Venereologica 60(3): 274-275
1980
ISSN/ISBN: 0001-5555 PMID: 6158237 Document Number: 157074
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.